Skip to main
DHR

Danaher (DHR) Stock Forecast & Price Target

Danaher (DHR) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 47%
Buy 35%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Danaher is an industrial-focused manufacturing company that aims to provide high-quality scientific instruments and consumables to the life sciences and diagnostic industries. Its strong track record of organic growth, continuous improvement through the Danaher Business System, and strategic mergers and acquisitions make it a compelling investment opportunity. Additionally, the recent divestiture of its environmental and applied solutions group will allow Danaher to further focus on its core segments and potentially drive even stronger financial performance. With a relatively low P/E ratio compared to the S&P 500, Danaher's stock appears undervalued and presents a potential buying opportunity for investors.

Bears say

Danaher is a former real estate organization that has transformed into a primarily industrial-focused manufacturing company, with a recent focus on the life sciences and diagnostic industries. However, the company's growth is highly dependent on the bioprocessing sector, which may face challenges in the future. Additionally, there are risks to the company's growth and acquisitions may not meet expectations. While the company has shown progress in diversifying its management ranks, there is still room for improvement in terms of diversity. Overall, there are concerns about the company's future growth potential and potential risks related to acquisitions and industry changes.

Danaher (DHR) has been analyzed by 17 analysts, with a consensus rating of Buy. 47% of analysts recommend a Strong Buy, 35% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Danaher and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Danaher (DHR) Forecast

Analysts have given Danaher (DHR) a Buy based on their latest research and market trends.

According to 17 analysts, Danaher (DHR) has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $235.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $235.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Danaher (DHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.